BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors

Clinical trial NCT05120271 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05120271
Sponsor: Sotio Biotech Inc.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma Squamous Cell Carcinoma of the Lung Merkel Cell Carcinoma Myxoid/Round Cell Liposarcoma

Start date: 2022-10-26
Primary completion: 2025-10-24
Enrollment: 7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.